Your browser is no longer supported. Please, upgrade your browser.
Settings
MYOS MYOS RENS Technology Inc. daily Stock Chart
MYOS [NASD]
MYOS RENS Technology Inc.
Index- P/E- EPS (ttm)-0.04 Insider Own43.87% Shs Outstand7.46M Perf Week-1.67%
Market Cap8.80M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float4.27M Perf Month-3.77%
Income-0.40M PEG- EPS next Q- Inst Own1.80% Short Float8.57% Perf Quarter-6.42%
Sales0.50M P/S17.61 EPS this Y93.20% Inst Trans- Short Ratio11.30 Perf Half Y-25.32%
Book/sh0.51 P/B2.31 EPS next Y- ROA-91.60% Target Price- Perf Year-11.28%
Cash/sh0.07 P/C17.61 EPS next 5Y- ROE-101.80% 52W Range1.03 - 2.50 Perf YTD-13.01%
Dividend- P/FCF- EPS past 5Y50.80% ROI-8.50% 52W High-52.80% Beta1.27
Dividend %- Quick Ratio1.50 Sales past 5Y-10.40% Gross Margin51.90% 52W Low14.56% ATR0.08
Employees10 Current Ratio5.70 Sales Q/Q0.00% Oper. Margin- RSI (14)44.14 Volatility9.39% 6.50%
OptionableNo Debt/Eq0.00 EPS Q/Q24.60% Profit Margin- Rel Volume0.19 Prev Close1.18
ShortableNo LT Debt/Eq0.00 EarningsNov 13 AMC Payout- Avg Volume32.35K Price1.18
Recom- SMA20-4.61% SMA50-5.16% SMA200-11.31% Volume3,879 Change0.00%
Nov-14-18 04:15PM  MYOS RENS Technology Reports Financial Results for the Third Quarter of 2018 and Business Updates PR Newswire -7.09%
Nov-08-18 06:10AM  MYOS RENS Technology Signs Distribution Agreement With Miller Veterinary Supply East To Bring Innovative MYOS Canine Muscle Formula To 6,000+ Veterinary Hospitals PR Newswire
Nov-06-18 05:26PM  MYOS RENS Technology Announces The Date For The Release Of Third Quarter 2018 Results, Conference Call And Webcast PR Newswire +5.79%
Oct-16-18 08:20AM  Investor Expectations to Drive Momentum within Pacific Ethanol, CorVel, Surmodics, Alpha and Omega Semiconductor, MYOS RENS Technology, and Golden Entertainment Discovering Underlying Factors of Influence GlobeNewswire
Oct-02-18 06:10AM  Centers For Medicare and Medicaid Services Approves Reimbursement For Unique Fortetropin®-Based Enteral Nutrition Formula PR Newswire
Sep-26-18 07:00AM  MYOS RENS Technology To Exhibit MYOS Canine Muscle Formula At The Atlantic Coast Veterinary Conference, October 8-11, 2018 PR Newswire
Sep-11-18 11:20AM  Should You Have MYOS RENS Technology Incs (NASDAQ:MYOS) In Your Portfolio? Simply Wall St.
Aug-17-18 02:00PM  MYOS: Yolked Well-Received, MYOS Canine Formula Launched Zacks Small Cap Research
08:20AM  Consolidated Research: 2018 Summary Expectations for PDF Solutions, MYOS RENS Technology, Aldeyra Therapeutics, The Ensign Group, Everi, and Ardelyx Fundamental Analysis, Key Performance Indications GlobeNewswire
Aug-08-18 05:39PM  MYOS RENS Technology Reports 49% Increase In Net Revenues In Second Quarter Of 2018 PR Newswire
Aug-02-18 06:15AM  MYOS RENS Technology Announces The Date For The Release Of Second Quarter And First Half 2018 Results, Conference Call And Webcast PR Newswire -10.14%
Jul-12-18 08:00AM  Today's Research Reports on Trending Tickers: MYOS RENS Technology and Canopy Growth ACCESSWIRE -25.38%
Jun-06-18 06:10AM  MYOS RENS Technology Launches Advanced Veterinary Supplement Product For Dogs, Powered By Fortetropin® PR Newswire
May-31-18 07:55AM  Factors of Influence in 2018, Key Indicators and Opportunity within Insulet, Everi, Ciner Resources LP, Aluminum Corporation of China, Okta, and MYOS RENS Technology New Research Emphasizes Economic Growth GlobeNewswire -5.01%
May-24-18 10:11AM  Should You Buy MYOS RENS Technology Inc (NASDAQ:MYOS) Now? Simply Wall St.
May-16-18 09:45AM  MYOS: Several Development-Related Milestones Upcoming Zacks Small Cap Research
May-09-18 05:36PM  MYOS RENS Technology Reports First Quarter Financial Results PR Newswire +13.14%
May-03-18 08:02PM  /C O R R E C T I O N -- MYOS RENS Technology Inc./ PR Newswire -6.47%
Apr-20-18 07:20AM  Free Research Report as Lipocine Announced FY17 Financial Results ACCESSWIRE
Apr-12-18 10:00AM  MYOS: A New Product For Sports Nutrition Zacks Small Cap Research
Apr-10-18 09:11AM  Was MYOS RENS Technology Incs (NASDAQ:MYOS) Earnings Growth Better Than The Industrys? Simply Wall St.
06:10AM  MYOS RENS Technology Introduces New Sports Nutrition Product Line, Yolked, and Earns Prestigious "Certified For Sport®" Certification From NSF International PR Newswire
Apr-06-18 07:55AM  Detailed Research: Economic Perspectives on VASCO Data Security International, Constellation Brands, MYOS RENS Technology, Avadel Pharmaceuticals, Energizer, and BJ's Restaurants What Drives Growth in Today's Competitive Landscape GlobeNewswire
Apr-03-18 03:15PM  MYOS: Initiation Report Zacks Small Cap Research +8.06%
02:54PM  MYOS RENS Technology to Present at the MicroCap Conference April 10 in New York City at the Essex House PR Newswire
Mar-28-18 01:53PM  MYOS RENS Technology CEO Joseph Mannello Provides Comments On Operational And Financial Results For Fiscal Year 2017 PR Newswire
08:00AM  MYOS RENS Technology Inc. to Host Earnings Call ACCESSWIRE
Mar-27-18 05:48PM  MYOS RENS Technology Reports Fourth Quarter And Fiscal 2017 Financial Results PR Newswire
06:10AM  MYOS RENS Technology, Inc. Announces Research Agreement with Rutgers University Focused on Discovery of Compounds and Products for Improving Muscle Health and Performance PR Newswire
Mar-20-18 04:19PM  MYOS RENS Technology Announces the Date for the Release of Fourth Quarter and Year Ended December 31, 2017 Results, Conference Call and Webcast PR Newswire
Mar-05-18 07:35AM  Detailed Research: Economic Perspectives on Lear, MYOS RENS Technology, Dollar Tree, Halliburton, Waters, and ANI Pharmaceuticals What Drives Growth in Today's Competitive Landscape GlobeNewswire
Feb-15-18 06:05AM  MYOS RENS Technology to Showcase Fortetropin® and the Qurr® Line of Muscle Health Products at the 2018 Arnold Sports Festival in Columbus, OH from March 2-4, 2018 PR Newswire
Jan-16-18 06:05AM  MYOS RENS Technology Launches 30-Day Qurr® Fortetropin® Challenge PR Newswire
Jan-11-18 06:05AM  MYOS RENS Technology CEO Issues Shareholder Letter PR Newswire
Dec-06-17 06:05AM  MYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And Women PR Newswire
Nov-14-17 06:10AM  MYOS RENS Technology Reports Third Quarter 2017 Financial Results PR Newswire +14.67%
Nov-08-17 06:05AM  MYOS RENS Technology Inc. Launches Collegiate Sports Marketing Platform PR Newswire
Nov-03-17 02:59PM  Who Really Owns MYOS RENS Technology Inc (MYOS)? Simply Wall St. -6.35%
Oct-26-17 06:10AM  Pro Football Legends, the Commercial Marketing Arm of the NFL Alumni, Launches Partnership with MYOS RENS Technology Inc. in Optimal Bowl and Wellness Challenge PR Newswire -5.37%
Sep-20-17 09:03AM  MYOS RENS Technology Inc. Appoints Joseph Mannello as Permanent Chief Executive Officer PR Newswire -8.81%
Aug-24-17 11:28AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Jul-12-17 06:12AM  MYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las Vegas PR Newswire
Jun-02-17 09:54AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
Apr-24-17 06:05AM  MYOS RENS Will Be Silver Sponsor at International Conference on Frailty and Sarcopenia Research (ICFSR) PR Newswire +6.67%
Apr-18-17 06:05AM  MYOS RENS enters into agreement with Kansas State University to study impact of Fortetropin® on reducing muscle loss in dogs after joint surgery PR Newswire +5.80%
Apr-06-17 12:05PM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q4, 2016 By the Numbers : April 6, 2017 Capital Cube
09:54AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: 2016 By the Numbers : April 6, 2017 Capital Cube
Mar-31-17 06:11AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report
06:01AM  MYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launch PR Newswire
Mar-13-17 06:00AM  Are you Qurr-ious? MYOS Rens Technology Inc. Launches Qurr Product Line Powered by Fortetropin®, an All-Natural Ingredient Clinically Proven to Increase Muscle Size and Mass PR Newswire
Mar-01-17 03:26PM  'Qurr' line of revolutionary muscle-health and muscle-building products in newly-enhanced form set for March rollout Marketwired +11.55%
Feb-21-17 08:36AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex -17.85%
Feb-14-17 06:13PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Ri
06:00PM  MYOS RENS Technology Inc. Adopts Shareholder Rights Plan Marketwired
Feb-07-17 05:05PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, F +30.75%
Feb-06-17 09:30AM  Key Catalyst That Could Send Biotechs Soaring in 2017: Today's Reports on MYOS RENS Technology and Actinium Pharmaceuticals Accesswire
Feb-03-17 02:54PM  MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering Marketwired +37.22%
Jan-30-17 08:00AM  Dr. Robert Hariri, stem cell pioneer and chairman of MYOS RENS Technology, states that 'healthy muscle is key to overall health and wellness' Marketwired
Jan-23-17 04:43PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers -7.47%
Jan-11-17 04:46PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other +424.62%
Dec-22-16 04:31PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-25-16 08:01AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement +6.00%
Nov-22-16 01:04PM  MYOS RENS TECHNOLOGY INC. Financials
Nov-18-16 11:46AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Capital Cube
Nov-14-16 04:13PM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report +6.90%
Sep-29-16 08:00AM  MYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript Marketwired
Sep-07-16 12:32PM  MYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer Marketwired
Aug-31-16 08:01AM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers
Aug-24-16 04:17PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
Aug-12-16 08:34AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report
Aug-08-16 04:35PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-29-16 04:17PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-22-16 11:58AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 Capital Cube
May-20-16 05:26PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant
May-13-16 08:34AM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report
Apr-22-16 03:00PM  MYOS Reports Positive Results From Fortetropin(R) Clinical Study Marketwired
Apr-11-16 08:51AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q4, 2015 By the Numbers
07:49AM  MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: 2015 By the Numbers
Mar-30-16 05:53PM  MYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report
Mar-23-16 05:21AM  MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc. at noodls
Mar-22-16 04:33PM  MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ
07:33AM  MYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc. Marketwired
Mar-08-16 05:31PM  MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Cha
04:17PM  MYOS Corporation Announces Election of New Directors and Appointment of Ren Ren as Global Chairman Marketwired
Mar-04-16 08:30AM  MYOS Corporation Announces the Initial Closing of a Strategic Investment by RENS Technology Inc. Marketwired
Feb-04-16 05:21PM  MYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
Dec-22-15 05:09PM  MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation o
Dec-21-15 04:32PM  MYOS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters
Dec-17-15 01:55PM  Why Are These Stocks Gaining Ground on Thursday? at Insider Monkey
11:00AM  4 Stocks Under $10 That Need To Be Watched Today Accesswire
08:00AM  MYOS Corporation Announces Strategic Investment by RENS Technology Inc. Marketwired
Nov-30-15 05:21PM  MYOS CORP Files SEC form 8-K, Other Events
Nov-16-15 05:15PM  MYOS CORP Files SEC form 10-Q, Quarterly Report
Nov-03-15 12:08PM  MYOS Corp. Value Analysis (NASDAQ:MYOS) : November 3, 2015
Oct-26-15 07:35AM  Maintaining Muscle Linked to Preserving Healthy Brain Tissue Marketwired
Oct-19-15 07:35AM  MYOS' Proprietary Muscle Building Technology Fortetropin: Foundation for New Dietary Recommendations Marketwired
Oct-02-15 10:53AM  MYOS Corp. Earnings Q2, 2015
Oct-01-15 08:00AM  Cryoport Appoints Robert Hariri, MD, PhD to its Board of Directors PR Newswire
Aug-20-15 04:17PM  MYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers
Aug-16-15 08:12PM  10-Q for MYOS Corp. at Company Spotlight
MYOS RENS Technology Inc., a bionutrition and biotherapeutics company, focuses on the discovery, development, and commercialization of nutritional and therapeutic products for maintaining and enhancing the health and performance of muscle tissue. The company primarily focuses on developing the products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity. Its products include Re Muscle Health products, a direct-to-consumer portfolio of muscle health bars, meal replacement shakes, and daily supplement powders; and Qurr line of products comprising flavored puddings, powders, and shakes. The company sells its Re Muscle Health products through e-commerce Website remusclehealth.com; and Qurr line of products through convenient direct online ordering without a prescription. MYOS RENS Technology Inc. has a research agreement with the University of California to study the effects Of FortetropinA on skeletal muscle protein synthetic rate in older men and women; and Rutgers University for the discovery development and commercialization of products that improve muscle health and performance. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mannello JosephChief Executive OfficerDec 21Buy1.4620,33629,691274,765Dec 26 04:53 PM
Mannello JosephChief Executive OfficerDec 08Buy1.355,5007,425254,429Dec 08 07:49 PM
Mannello JosephChief Executive OfficerDec 07Buy1.3615,80021,488249,429Dec 08 07:49 PM
Mannello JosephChief Executive OfficerDec 06Buy1.3516,81922,706233,629Dec 08 07:49 PM
Mannello JosephChief Executive OfficerNov 16Buy1.3512,15016,403216,810Nov 16 05:13 PM